Understanding Metastatic Gastric Cancer
Metastatic gastric cancer, also called stage 4 stomach cancer or advanced gastric cancer, occurs when cancer that began in the stomach spreads to other parts of the body. The term metastatic describes the process where cancer cells break away from the original tumor and travel through blood or lymphatic vessels to establish new tumors in distant organs.[2] When examined under a microscope, these cancer cells in the new locations still resemble those from the stomach, which is why they are classified as stomach cancer even when found in the liver, lungs, or elsewhere.[4]
Sometimes stomach cancer is discovered at an advanced stage right at the first diagnosis. In other cases, cancer that was previously treated returns and spreads to new areas of the body. Both situations are considered metastatic disease.[2] Healthcare providers may also refer to these cancers as secondary cancer, metastases, or simply advanced cancer.[2]
Unfortunately, advanced stomach cancer cannot usually be cured. However, treatments exist that may control the cancer’s growth, reduce symptoms, and improve quality of life for a period of time.[2] The primary goal shifts from cure to managing the disease and helping patients maintain comfort and function as long as possible.
Where Stomach Cancer Spreads
Metastatic gastric cancer follows predictable patterns when it spreads throughout the body. The most common site is the liver, where nearly half of all patients with metastatic disease develop tumors.[3] This happens because blood flowing from the stomach passes through the liver, making it a natural destination for traveling cancer cells.
The peritoneum—the thin tissue lining the abdominal cavity—is affected in about one-third of metastatic cases.[3] When cancer spreads here, it can cause fluid buildup in the abdomen called ascites, leading to swelling and discomfort.[4] The lungs are involved in approximately 15% of cases, and bones in about 12% of patients.[3] Less commonly, stomach cancer may spread to lymph nodes distant from the stomach, the nervous system, ovaries, or bladder.[2][4]
The pattern of spread can vary depending on where the original tumor was located in the stomach. Cancers in the upper part of the stomach near the gastroesophageal junction (where the esophagus meets the stomach), called cardia cancers, tend to spread more frequently to the lungs, bones, and nervous system, particularly in men. Cancers in the lower portions of the stomach, known as non-cardia cancers, more often spread to the peritoneum.[3]
The type of cancer cells also influences spread patterns. Signet ring adenocarcinoma—a specific cell type named for its ring-like appearance under the microscope—more commonly spreads to the peritoneum, bones, and ovaries, while spreading less frequently to the lungs and liver compared to other types of stomach cancer.[3]
Epidemiology: Who Gets Metastatic Gastric Cancer
Gastric cancer ranks as the fourth most common cancer worldwide and the second leading cause of cancer-related death globally, though rates vary dramatically by geography.[3] The highest incidence occurs in Eastern Asia, particularly in Japan and Mongolia, and in Eastern Europe. By contrast, Northern Europe and Northern America show much lower rates, similar to those found in many African regions.[8]
In the United States, stomach cancer accounts for only about 1.5% of all cancers diagnosed each year.[4] For 2025, estimates suggest around 30,300 new cases and 10,780 deaths from gastric cancer.[10] What was once the leading cause of cancer death in the early 20th century has declined substantially, with new cases dropping by approximately 1.5% annually over the past decade.[1]
Age is a significant factor in stomach cancer diagnosis. The average age at diagnosis is 68 years, and about 60% of cases occur in people older than 65.[1] However, an interesting trend has emerged: among young adults aged 25 to 39 years, the incidence of non-cardia gastric cancers increased from 0.27 cases per 100,000 people in 1977-1981 to 0.45 cases per 100,000 in 2002-2006.[10] This rise in younger populations requires further study to understand its causes.
Men face a slightly higher lifetime risk of developing stomach cancer compared to women.[1] The disease can affect anyone, though certain populations show higher rates based on genetic background and geographic origin.
Causes of Stomach Cancer
Stomach cancer develops slowly over many years through a gradual process of cellular changes. The disease begins when small alterations occur in the DNA of stomach cells—the genetic material that provides instructions for cell function. These mutations tell cells to multiply excessively and avoid the normal death that older cells undergo. Over time, these abnormal cells accumulate and form masses called tumors.[1]
Most stomach cancers—approximately 90% to 95%—are adenocarcinomas, which develop from the glandular cells in the stomach’s innermost lining, called the mucosa.[10] These glandular cells normally produce protective mucus and digestive juices. The stomach wall consists of five layers: the mucosa (innermost), submucosa, muscle layer, subserosa, and serosa (outermost).[7] As cancers advance, they spread from the mucosa outward through these layers.
In the United States, most stomach cancers occur at the gastroesophageal junction where the esophagus meets the stomach. The incidence of these junction cancers increased sharply from the 1970s through the late 1980s, from 1.22 cases per 100,000 people to 2.00 cases per 100,000, though rates have since stabilized.[10] Meanwhile, cancers in the lower parts of the stomach have generally decreased, except for the noted increase in younger adults.
Risk Factors for Developing Gastric Cancer
Several factors increase the likelihood of developing stomach cancer. One of the most significant is infection with Helicobacter pylori, a bacterium that lives in the stomach lining and can cause chronic inflammation.[10][8] Over many years, this persistent inflammation can lead to changes in stomach cells that eventually become cancerous.
Diet plays an important role in stomach cancer risk. Eating large amounts of salted, smoked, or preserved foods increases risk, while diets rich in fresh fruits and vegetables appear protective.[10] Cigarette smoking and alcohol consumption also contribute to elevated risk.[8]
Certain stomach conditions raise cancer risk significantly. Chronic atrophic gastritis—long-term inflammation that causes thinning of the stomach lining—creates an environment where cancer can develop.[10] Intestinal metaplasia, where normal stomach lining cells are replaced by intestinal-type cells, represents another precancerous change. People with pernicious anemia, a condition where the body cannot absorb enough vitamin B12, face increased risk, as do those with gastric adenomatous polyps—abnormal tissue growths in the stomach.[10]
Family history matters as well. Having close relatives with stomach cancer increases personal risk, suggesting both genetic and shared environmental factors.[10] Some people inherit DNA mutations that significantly elevate their risk, including those with familial adenomatous polyposis and other hereditary cancer syndromes.[10][11] Multiple factors raising suspicion for hereditary cancer include developing cancer at a younger age, having a personal history of other cancers, or multiple family members with cancer.[11]
Other risk factors include infection with Epstein-Barr virus, a common virus that usually causes mild illness but can contribute to certain cancers, and rare conditions like Ménétrier disease, which causes abnormally large folds in the stomach lining.[10]
Recognizing Symptoms of Metastatic Gastric Cancer
The symptoms of metastatic stomach cancer depend partly on where the cancer has spread, though many people experience general symptoms from the primary tumor as well. Common symptoms include persistent indigestion or heartburn that doesn’t respond to usual treatments, a feeling of fullness or bloating in the abdomen even after small meals, and ongoing nausea.[4]
Many patients notice a loss of appetite and unintentional weight loss—losing pounds without trying to diet or increase activity.[4] Vomiting may occur, sometimes containing blood, and blood may also appear in the stool, making it look dark, tarry, or black. Abdominal pain is common, ranging from mild discomfort to severe cramping.
When cancer spreads to specific organs, additional symptoms emerge. Spread to the liver can cause jaundice—a yellowing of the skin and whites of the eyes—as the liver’s function becomes impaired.[4] Cancer in the peritoneum often leads to ascites, causing the abdomen to swell with fluid. This makes clothes feel tight and can cause shortness of breath if fluid pushes up against the diaphragm.
Bone metastases may cause bone pain and increase the risk of fractures, as cancer weakens the bone structure.[4] When cancer affects the bladder or bowels, patients might experience blood in the urine, pain during urination or bowel movements, and changes in toilet habits.[4] Difficulty swallowing, called dysphagia, occurs when tumors block the opening between the esophagus and stomach.[4]
Advanced cancer often causes profound tiredness that rest doesn’t relieve, and a general feeling of being unwell. This exhaustion, called fatigue, results from the cancer itself, from treatments, or from complications like anemia (low red blood cell counts).[17]
Prevention Possibilities
While there is no guaranteed way to prevent stomach cancer from spreading once it has developed, certain lifestyle factors may help the body resist cancer progression and support overall health. Maintaining or reaching a moderate body weight appears beneficial, as excess weight can contribute to various health complications.[4]
For those who smoke, stopping tobacco use is one of the most important steps. Smoking damages cells throughout the body and impairs the immune system’s ability to fight cancer.[4] Similarly, reducing alcohol consumption may help, as alcohol has been linked to increased cancer risk.
Nutrition takes on special importance in stomach cancer. Eating a balanced diet rich in fresh fruits and vegetables provides essential nutrients and compounds that support the body’s defenses.[4] However, patients with stomach cancer often struggle with eating due to symptoms like nausea, early fullness, and changes in taste. Working with healthcare providers and dietitians becomes crucial to maintain adequate nutrition.
Regular screening and early detection of stomach problems can identify precancerous changes before cancer develops or spreads. However, stomach cancer screening is not routine in most Western countries due to low incidence rates. In countries where stomach cancer is common, such as Japan, screening programs have proven effective at catching cancer early.
Researchers are studying something called the pre-metastatic niche—a concept that describes how the primary tumor sends signals through the bloodstream that prepare distant sites to receive and support cancer cells.[4] Understanding this process may one day lead to interventions that prevent cancer from establishing itself in new locations.
How Metastatic Gastric Cancer Affects the Body
Understanding the physical changes caused by metastatic gastric cancer helps explain why certain symptoms occur and why treatment approaches are chosen. The disease affects the body through multiple mechanisms that go beyond just the presence of tumor masses.
As cancer grows in the stomach, it can physically block the passage of food. Tumors may obstruct the opening where the esophagus enters the stomach or where the stomach empties into the small intestine. This blockage prevents normal eating and digestion, causing pain, severe nausea, and vomiting. Patients may require procedures to open these passages, such as placement of a stent—a hollow tube that holds the opening wide—or laser therapy to burn away blocking tumor tissue.[15][17]
When cancer spreads to the peritoneum, it triggers fluid production that accumulates in the abdominal cavity as ascites. This fluid contains nutrients and growth factors that actually feed the cancer cells, creating a self-perpetuating cycle. The fluid buildup increases pressure inside the abdomen, compressing organs and making breathing difficult.
Liver metastases disrupt the liver’s critical functions, including processing nutrients, making proteins needed for blood clotting, and removing toxins from blood. As liver function declines, toxins accumulate, contributing to confusion, fatigue, and jaundice. The liver’s reduced ability to produce clotting factors increases bleeding risk.
Cancer throughout the body triggers widespread inflammatory responses. The immune system recognizes cancer cells as abnormal and attempts to fight them, releasing inflammatory chemicals that cause systemic effects. These inflammatory signals contribute to fatigue, fever, night sweats, and loss of appetite. They also drive cachexia—a syndrome of muscle wasting and weight loss that occurs despite adequate calorie intake.
Tumors consume large amounts of the body’s nutrients and energy, essentially competing with normal tissues for resources. This metabolic demand, combined with poor food intake due to symptoms and changes in how the body processes nutrients, leads to severe malnutrition. Malnutrition weakens the immune system, reduces treatment tolerance, impairs wound healing, and significantly impacts quality of life.[21]
Pain in metastatic gastric cancer arises from multiple sources. Tumors can directly invade nerves, stretch organs as they grow, or cause inflammation in surrounding tissues. Bone metastases cause pain by disrupting normal bone structure and triggering inflammatory responses around affected areas.
Prognosis and Survival
Learning about prognosis—the likely course and outcome of the disease—is deeply personal. Some people want detailed information about survival statistics, while others prefer not to focus on numbers. Both approaches are valid, and patients should feel comfortable discussing with their healthcare team what level of detail feels right for them.[2]
The prognosis for metastatic gastric cancer is generally serious. The median overall survival—the time at which half of patients are still living—is typically measured in months rather than years. Without treatment, advanced gastric cancer usually results in survival of only 3 to 5 months.[6][14]
Treatment significantly extends survival. For patients receiving chemotherapy alone as their main treatment, median survival ranges from about 7 months in real-world settings to 6 to 14 months in clinical trials, with newer treatments sometimes achieving longer times.[6][9][14] When carefully selected patients can undergo surgery to remove the primary tumor in addition to receiving chemotherapy, median survival extends to about 14 months.[6][14]
The median survival for metastatic gastric cancer overall is approximately 3 months across all treatment types and patient conditions.[3] Survival is shortest among patients with bone or liver metastases, where median survival is around 2 months.[3] However, these are statistical averages—individual experiences vary widely based on many factors including age, overall health, cancer characteristics, treatment response, and access to supportive care.
Several factors influence prognosis. Younger age at diagnosis generally associates with better outcomes. The specific year of diagnosis matters too, as newer treatments have gradually improved results over time. Tumor characteristics like grade—how abnormal the cancer cells look under a microscope—provide prognostic information, with higher-grade tumors typically behaving more aggressively.[6][14]
For localized stomach cancer caught before it spreads, more than 50% of patients can be cured with surgery and additional treatments. However, only 10% to 20% of stomach cancers in the United States are diagnosed at this early stage.[10] By the time cancer has spread to distant sites, cure is rarely achieved, so treatment goals focus on prolonging life and maintaining quality of life.[5][11]
Every person’s cancer journey is unique. Your doctor and specialized cancer team, who know all the specific details about your situation, are the best sources for discussing what to expect in your individual case.[2]
Diagnosis and Testing
Diagnosing metastatic gastric cancer involves multiple steps and various tests to confirm cancer presence, determine its extent, and identify characteristics that guide treatment decisions. The process typically begins with a thorough physical examination where doctors feel the abdomen for masses or unusual features, and review medical history including family cancer history.[4]
Blood tests provide important information about overall health. A complete blood count measures red blood cells, white blood cells, and platelets, which can be affected by cancer or its treatments. Other blood tests assess liver function, kidney function, and nutritional status.[4]
An upper endoscopy represents a key diagnostic tool. During this procedure, a doctor passes a thin, flexible tube with a light and camera through the mouth, down the esophagus, and into the stomach to directly visualize the stomach lining. If suspicious areas are seen, small tissue samples called biopsies can be taken for microscopic examination.[4] This tissue analysis confirms whether cancer is present and identifies the cancer type.
A barium swallow, also called an upper GI series, involves drinking a chalky liquid containing barium that coats the stomach lining. X-rays taken after drinking this contrast material can reveal abnormalities in the stomach’s shape or function.[4]
Imaging tests determine whether and where cancer has spread. CT scans (computed tomography scans) use X-rays taken from multiple angles to create detailed cross-sectional images of the body, revealing tumors in the abdomen, chest, and other areas.[4] PET scans (positron emission tomography) involve injecting a small amount of radioactive sugar that cancer cells absorb readily; areas of high sugar uptake appear bright on the scan, highlighting active cancer sites.[4]
Modern cancer care increasingly relies on molecular testing of tumor tissue to identify specific characteristics that inform treatment choices. Testing for HER2 (human epidermal growth factor receptor 2) protein levels is particularly important, as patients with HER2-positive tumors benefit from targeted therapies specifically designed to block this protein.[9][15] Other important markers include PD-L1 (programmed cell death ligand 1) expression and microsatellite instability (MSI) status, which help predict response to immunotherapy treatments.[8]
These molecular and genetic tests on cancer tissue help classify tumors beyond just their appearance under a microscope. This classification based on molecular biomarkers creates opportunities for personalized treatment strategies tailored to each patient’s specific cancer characteristics.[8]
Treatment Approaches
Treatment for metastatic gastric cancer aims to control the disease, relieve symptoms, and maintain quality of life. Because cure is rarely possible at this stage, treatment decisions balance potential benefits against side effects and impact on daily functioning.
Chemotherapy serves as the main treatment approach for metastatic disease. These drugs work by targeting rapidly dividing cells, which includes cancer cells. Chemotherapy is usually given as combinations of two or more drugs that work together more effectively than single agents. Common regimens include fluoropyrimidines (such as 5-fluorouracil or capecitabine) combined with platinum-based drugs (like cisplatin or oxaliplatin).[9][13][15] Two-drug combinations are often preferred because they cause fewer side effects than three-drug regimens while still providing benefit.[12]
Palliative chemotherapy—treatment given to relieve symptoms rather than cure—has been shown to prolong survival and improve quality of life more than supportive care alone.[9] However, no single standard chemotherapy regimen has been universally accepted as best for all patients with metastatic gastric cancer, and treatment must be individualized.
Targeted therapy represents an important advance in treating specific subgroups of patients based on their cancer’s molecular characteristics. Trastuzumab, a drug that targets the HER2 protein, was the first targeted therapy approved for gastric cancer. When added to chemotherapy in patients whose tumors produce excess HER2 protein (HER2-positive cancers), trastuzumab significantly improves survival.[9][15] This combination of chemotherapy plus trastuzumab has become the standard of care for HER2-positive metastatic gastric cancer.
Other targeted drugs have been developed more recently. Ramucirumab targets blood vessel growth and may be used alone or with chemotherapy when other treatments have stopped working.[15] Trastuzumab deruxtecan is a newer anti-HER2 agent that can be used after trastuzumab treatment.[15]
Immunotherapy helps the body’s own immune system recognize and attack cancer cells. These treatments work by blocking proteins that prevent immune cells from attacking tumors. Drugs called checkpoint inhibitors, such as nivolumab and pembrolizumab, may be combined with chemotherapy for treating advanced stomach cancer.[15] Immunotherapy has shown particularly impressive results in patients whose tumors have microsatellite instability or high levels of PD-L1.[8]
Surgery is not typically recommended for curing metastatic disease, as cancer in distant organs cannot be completely removed. However, surgery plays an important role in relieving specific symptoms—called palliative surgery. Procedures might remove part of the stomach if the tumor is bleeding severely or blocking food passage.[14][15] Doctors may place a stent to hold open blocked passages, allowing patients to swallow more easily.[15][17] In some carefully selected patients who respond very well to chemotherapy, surgery to remove the primary tumor combined with ongoing chemotherapy may extend survival longer than chemotherapy alone.[6][14]
Radiation therapy uses high-energy beams to kill cancer cells in specific areas. For metastatic disease, radiation is primarily used to relieve symptoms rather than cure cancer. It can effectively reduce pain, stop bleeding, relieve difficulty swallowing, or shrink tumors that are pressing on other organs.[15] Radiation may be given alone or combined with chemotherapy, called chemoradiation.
For patients with bowel obstruction—where the intestine becomes blocked by cancer—surgery might remove or bypass the blocked section to restore function.[15] When cancer blocks the stomach outlet, laser therapy can burn away tumor tissue blocking the passage.[17]
A feeding tube may be placed surgically when blockages cannot be relieved or when patients cannot eat enough by mouth. This tube delivers liquid nutrition directly into the stomach or small intestine, helping maintain nutritional status.[15]
Managing Symptoms and Supportive Care
Managing symptoms effectively is crucial for maintaining quality of life with metastatic gastric cancer. A comprehensive approach addresses physical symptoms, nutritional challenges, and emotional needs.
Tiredness and fatigue affect nearly everyone with advanced cancer. While some tiredness is inevitable, many interventions can help. Treating anemia with medications that stimulate red blood cell production or blood transfusions can significantly boost energy levels.[17] Balancing rest with light activity often helps more than complete rest alone. Short walks or gentle exercises, even while sitting or lying down, can paradoxically increase energy levels. Working with a physiotherapist to develop an appropriate exercise program tailored to individual abilities can be beneficial.[17]
Nutritional challenges require specialized attention. Many patients lose their appetite and struggle to maintain weight. Eating several small meals and snacks throughout the day is often easier than attempting three large meals.[17] High-calorie nutritional drinks recommended by dietitians can boost calorie intake without requiring large volumes of food. Eating whatever appeals at the moment, rather than forcing oneself to eat foods perceived as “healthy,” often works better. Even when solid food intake is poor, maintaining adequate hydration remains essential.[17]
Early involvement of a registered dietitian who specializes in oncology nutrition is strongly recommended. These professionals can assess nutritional status, recommend specific supplements, suggest strategies to manage eating difficulties, and help prevent or address malnutrition.[19][21] Malnutrition significantly impacts ability to tolerate treatment, quality of life, and survival, making nutritional support a priority.[21]
Nausea and vomiting have multiple potential causes including cancer treatments, pain medications, constipation, or the cancer itself. Identifying the specific cause allows targeted treatment. Modern anti-nausea medications are quite effective when properly selected.[17] Some people find natural remedies helpful, such as ginger in various forms—fresh ginger boiled in water, crystallized ginger candy, or ginger-flavored drinks.[17]
Pain management deserves careful attention. Many different pain medications exist, and they can be taken in various ways—by mouth, through skin patches, or by injection. With proper medication selection and dosing, most patients can achieve good pain control most of the time.[17] Patients should never feel they must endure pain stoically; communicating openly with healthcare providers about pain allows adjustments to achieve comfort.
Blockages in the stomach or intestines cause severe symptoms requiring urgent medical attention. Besides surgical interventions, treatments with stents or laser therapy can rapidly relieve these blockages.[17] Some medications can help reduce the amount of fluid or gas produced, easing pressure and discomfort.
A multidisciplinary team approach provides the most comprehensive care. This team typically includes medical oncologists, surgeons, radiation oncologists, specialized nurses, dietitians, social workers, palliative care specialists, and mental health professionals.[21] Palliative care, which focuses on relieving suffering and improving quality of life, should be introduced early in the course of advanced cancer—not just at the end of life. Palliative care specialists work alongside cancer treatment teams to manage symptoms, provide emotional support, and help patients and families navigate difficult decisions.[2]
Emotional and Practical Support
Receiving a diagnosis of metastatic cancer that cannot be cured is profoundly distressing and often comes as a shock. It’s completely normal to feel unable to think about anything else initially, and to experience intense anxiety, fear, sadness, or anger. These emotional responses are valid and expected.[2]
Different people cope in different ways. Some find that learning more about their cancer and treatment options helps them feel more in control and better able to cope with the situation. Others prefer to know only basic information and take things one day at a time. There is no right or wrong approach—what matters is what feels right for you.[2]
Healthcare teams understand these varying needs and can adjust how much information they provide based on individual preferences. Patients can always ask for more detailed information later if they initially preferred minimal details, or request that healthcare providers focus only on essential information if feeling overwhelmed.
Support networks play vital roles in helping patients and families cope. This might include family members, friends, support groups where people with similar experiences can share and learn from each other, counseling services, and spiritual or religious communities. Many cancer centers offer support groups specifically for people with advanced cancer.[2]
Practical concerns often add stress to an already difficult situation. Social workers can help navigate financial challenges, connect patients with assistance programs, arrange transportation to medical appointments, and coordinate home care services. Understanding insurance coverage, exploring disability benefits, and accessing co-pay assistance programs for expensive medications can ease financial burdens.
Communication with healthcare providers and loved ones becomes increasingly important. Being open about symptoms, concerns, preferences for care, and goals helps ensure that treatment plans align with what matters most to each patient. Some people benefit from keeping a journal of symptoms and questions to discuss at appointments, or bringing a trusted friend or family member to help remember information shared during visits.
Advance care planning—making decisions about future medical care while still able to express preferences clearly—gives patients greater control over their care journey. This includes completing documents like advance directives or living wills, designating healthcare proxies to make decisions if one becomes unable to communicate, and discussing with loved ones and healthcare teams what types of interventions are desired or unwanted as disease progresses.
